Science & Technology Partners, L.P. Natera, Inc. Transaction History
Science & Technology Partners, L.P.
- $382 Billion
- Q2 2025
A detailed history of Science & Technology Partners, L.P. transactions in Natera, Inc. stock. As of the latest transaction made, Science & Technology Partners, L.P. holds 85,190 shares of NTRA stock, worth $13.6 Million. This represents 3.77% of its overall portfolio holdings.
Number of Shares
85,190
Previous 50,300
69.36%
Holding current value
$13.6 Million
Previous $7.11 Billion
102.34%
% of portfolio
3.77%
Previous 2.82%
Shares
3 transactions
Others Institutions Holding NTRA
# of Institutions
706Shares Held
125MCall Options Held
590KPut Options Held
260K-
Vanguard Group Inc Valley Forge, PA12.7MShares$2.03 Billion0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.2MShares$1.95 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.18 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.08 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.82MShares$773 Million3.66% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $15.5B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...